CNY 26.15
(1.67%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 9.08 Billion CNY | 20.84% |
2022 | 7.51 Billion CNY | 43.54% |
2021 | 5.23 Billion CNY | 17.21% |
2020 | 4.46 Billion CNY | 26.58% |
2019 | 3.52 Billion CNY | 27.57% |
2018 | 2.76 Billion CNY | 17.85% |
2017 | 2.34 Billion CNY | 14.27% |
2016 | 2.05 Billion CNY | 11.36% |
2015 | 1.84 Billion CNY | 10.63% |
2014 | 1.66 Billion CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 2.23 Billion CNY | 3.5% |
2024 Q2 | 2.15 Billion CNY | -6.28% |
2024 Q1 | 2.3 Billion CNY | -10.77% |
2023 Q4 | 2.58 Billion CNY | 19.39% |
2023 Q1 | 2.16 Billion CNY | -22.76% |
2023 Q2 | 2.17 Billion CNY | 0.18% |
2023 FY | 9.08 Billion CNY | 20.84% |
2023 Q3 | 2.16 Billion CNY | -0.41% |
2022 FY | 7.51 Billion CNY | 43.54% |
2022 Q4 | 2.8 Billion CNY | 64.76% |
2022 Q3 | 1.7 Billion CNY | 9.44% |
2022 Q2 | 1.55 Billion CNY | 7.28% |
2022 Q1 | 1.45 Billion CNY | -7.53% |
2021 FY | 5.23 Billion CNY | 17.21% |
2021 Q2 | 1.21 Billion CNY | 3.9% |
2021 Q4 | 1.56 Billion CNY | 21.85% |
2021 Q3 | 1.28 Billion CNY | 6.16% |
2021 Q1 | 1.16 Billion CNY | -8.83% |
2020 FY | 4.46 Billion CNY | 26.58% |
2020 Q1 | 1.05 Billion CNY | 2.88% |
2020 Q4 | 1.27 Billion CNY | 18.78% |
2020 Q3 | 1.07 Billion CNY | 2.32% |
2020 Q2 | 1.05 Billion CNY | -0.24% |
2019 FY | 3.52 Billion CNY | 27.57% |
2019 Q4 | 1.02 Billion CNY | 0.0% |
2018 FY | 2.76 Billion CNY | 17.85% |
2017 FY | 2.34 Billion CNY | 14.27% |
2017 Q1 | 538.81 Million CNY | 0.0% |
2017 Q2 | 538.81 Million CNY | 0.0% |
2016 FY | 2.05 Billion CNY | 11.36% |
2015 FY | 1.84 Billion CNY | 10.63% |
2014 FY | 1.66 Billion CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 1.81 Billion CNY | -399.072% |
Jointown Pharmaceutical Group Co., Ltd | 149.7 Billion CNY | 93.934% |
LBX Pharmacy Chain Joint Stock Company | 22.35 Billion CNY | 59.386% |
Yifeng Pharmacy Chain Co., Ltd. | 22.58 Billion CNY | 59.799% |